Document Detail


Acoustic attenuation by contrast agent microbubbles in superficial tissue markedly diminishes petechiae bioeffects in deep tissue.
MedLine Citation:
PMID:  18424953     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To measure how ultrasound attenuation by contrast agent microbubbles (MBs) in superficial tissue affects petechiae creation in underlying deep tissue.
MATERIALS AND METHODS: Studies using Sprague-Dawley rats were approved by the Animal Care and Use Committee. MBs were injected intravenously, and 12 ultrasound pulses (100 sinusoids of 1 MHz ultrasound per pulse) were applied through the skin overlying the hindlimb adductors at intervals of 10 or 60 seconds. In some groups, the skin was resected and immediately returned without re-establishing vascular connections. Muscle petechiae were counted.
RESULTS: Applying ultrasound through unperfused skin after bolus and continuous intravenous MB injection yielded, respectively, 30-fold and 3.5-fold more petechiae than for perfused skin. Surprisingly, petechiae/mm2 decreased with a higher MB dosage [0.12 +/- 0.05 (1 x 10 MBs/g) vs. 0.04 +/- 0.02 (3 x 10 MBs/g)] when ultrasound was applied through perfused skin. In contrast, petechiae/mm2 was approximately proportional to MB dosage for unperfused skin [0.17 +/- 0.10(5) (1 x 10 MBs/g) vs. 0.42 + 0.14 (3 x 10(5) MBs/g)]. In comparison to MB-free controls, MB solutions in this concentration range reduced the peak-negative pressure of ultrasound by 65% to 85%.
CONCLUSIONS: Acoustic attenuation by MBs in skin markedly reduces petechiae creation in deep muscle. Petechiae inhibition is dependent on [MB]2.1 and, therefore, dominates the otherwise proportional relationship between petechiae and [MB] in muscle. The drop of peak-negative pressure below a critical microvessel rupturing threshold is the probable mechanism for petechiae inhibition. These results indicate that high MB doses could, paradoxically, reduce the potential for petechiae creation and may have important bearing on the design of contrast ultrasound-based therapeutics.
Authors:
Ji Song; Alexander L Klibanov; John A Hossack; Richard J Price
Related Documents :
18025843 - Topical delivery of retinyl ascorbate. 3. influence of follicle sealing and skin stretc...
10985633 - Relevance of multiparametric skin bioengineering in a prospectively-followed cohort of ...
23728653 - Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron dise...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Investigative radiology     Volume:  43     ISSN:  0020-9996     ISO Abbreviation:  Invest Radiol     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-04-21     Completed Date:  2008-09-19     Revised Date:  2013-06-05    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  322-9     Citation Subset:  IM    
Affiliation:
Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Contrast Media / administration & dosage*
Hindlimb
Microbubbles*
Microcirculation
Muscle, Skeletal / ultrasonography*
Purpura / etiology,  prevention & control*
Rats
Rats, Sprague-Dawley
Ultrasonics*
Grant Support
ID/Acronym/Agency:
R01 HL074082-03/HL/NHLBI NIH HHS; R01 HL74082/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Contrast Media
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of coronary plaque by 64-slice computed tomography: a comparison with quantitative in...
Next Document:  Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase ...